India Cancels Novartis Vymada Patent, Opens Market to Generics
A major update has been released by the Indian Patent Office (IPO) that could significantly reshape the Indian pharmaceutical market. Novartis Vymada Patent Re…
Read moreCourt decisions, patent office updates and technology trends, explained by our attorneys and analysts for in-house teams, law firms and innovators.
Articles tagged patent eligibility Show all articles
A major update has been released by the Indian Patent Office (IPO) that could significantly reshape the Indian pharmaceutical market. Novartis Vymada Patent Re…
Read more
A big patent fight in the United States is making headlines as USAA’s long battle with major banks over mobile check deposit technology reaches the Supreme Cou…
Read more
Patenting is very complex and involves multiple stages, and the complexity increases when we try to file a patent in multiple regions or countries. In 2024–25,…
Read moreGet practical patent and trademark insights, deadlines and news from our team. No spam, unsubscribe any time.